logo
Talc Isn't Just in Baby Powder. It's Also in Vitamins and Drugs

Talc Isn't Just in Baby Powder. It's Also in Vitamins and Drugs

Bloomberg30-06-2025
Hey there, it's Anna in Virginia. I recently learned about a startling ingredient in many popular vitamins and drugs, but before we get to that ...
Multivitamins, cholesterol drugs, antibiotics. Besides aiming to make us healthier, these capsules and tablets have another thing in common: some of them contain talc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AleraCare and PURE Healthcare Announce Intent to Merge
AleraCare and PURE Healthcare Announce Intent to Merge

Yahoo

time18 minutes ago

  • Yahoo

AleraCare and PURE Healthcare Announce Intent to Merge

The combined company will create a leading ambulatory infusion platform with more than 75 outpatient locations across 14 states throughout the U.S. PHOENIX & TAYLORSVILLE, Utah, August 13, 2025--(BUSINESS WIRE)--AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and PURE Healthcare, a leading national medical group that delivers healthcare services for individuals with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, Alzheimer's disease and other autoimmune conditions, today announced that the businesses have entered into a definitive merger agreement. Terms of the transaction were not disclosed. The proposed merger creates an unprecedented opportunity to provide high-quality patient care, improve clinical outcomes and enhance the availability of infusion services that lower the overall cost to the healthcare system overall. Founded in 2019, AleraCare's core lines of business include ambulatory infusion centers, home infusion therapy and specialty pharmacy. Administered at convenient, accessible, patient-first locations, AleraCare is focused on maintaining trusted-partner status with physicians, payors, drug distributors and pharmaceutical manufacturers. The company has rapidly expanded to over 30 ambulatory infusion centers across the country and is a provider-of-choice for infusion services to high-need and medically complex populations. Pure Healthcare, founded in 2018, is on a mission to transform the healthcare industry by making infusion therapy more affordable and accessible—while delivering a personalized, patient-centered experience. Pure specializes in treating chronic and autoimmune conditions such as Alzheimer's disease, multiple sclerosis, and rheumatoid arthritis, offering innovative, high-quality care tailored to individual needs. Its flagship offering, Pure Infusion Suites, has expanded to 43 locations across 14 states. These state-of-the-art suites prioritize patient comfort with private rooms, snacks, and entertainment, all while significantly lowering the cost of infusion services. Pure Healthcare also alleviates the administrative burden for referring providers by supporting patient authorizations and fostering strong partnerships with insurers, ensuring a seamless and efficient care journey from referral to treatment. The transaction is expected to close in the fourth quarter of 2025, and remains subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Holland & Knight is serving as legal counsel for AleraCare. Kunzler Bean & Adamson is serving as legal counsel and Cantor Fitzgerald is acting as financial advisor for PURE Healthcare. About AleraCare AleraCare is a leading provider of infusion treatments and pharmacy services for high-need and medically complex populations. The company's core lines of business include ambulatory infusion centers, home infusion therapy and specialty pharmacy. AleraCare provides care to patients in over 30 locations across six states throughout the U.S., including Arizona, California, Colorado, Idaho, New Mexico and Utah. For more information, please visit About PURE Healthcare Pure Healthcare, founded by BUILD Capital Partners in 2018, is a national medical group dedicated to reducing healthcare costs and improving outcomes for patients with complex chronic and autoimmune conditions like rheumatoid arthritis, Crohn's disease, multiple sclerosis, and Alzheimer's. As a market leader in infusion therapy, Pure Healthcare operates Pure Infusion Suites alongside specialty clinics in rheumatology and neurology, including Memory Treatment Centers and Montana Arthritis Centers. Through strategic payer partnerships, streamlined patient authorizations, and a commitment to personalized, high-quality care, Pure Healthcare delivers scalable value to patients, providers, and payers nationwide. Learn more at View source version on Contacts Media Contacts:AleraCare Mike GellerProfile Advisorsmgeller@ Pure Healthcare Andy Sortormarketing@

‘Zombie' rabbits with black horns and mouth tentacles are invading Colorado backyards
‘Zombie' rabbits with black horns and mouth tentacles are invading Colorado backyards

Yahoo

time18 minutes ago

  • Yahoo

‘Zombie' rabbits with black horns and mouth tentacles are invading Colorado backyards

What the heck is that?! Rabbits in Colorado are causing alarm among residents and looking more like creatures from nightmares and not fuzzy and cuddly friends. Rabbits in Fort Collins, Colorado, are being spotted with eerie black-colored growths resembling tentacles or horns protruding from their heads. 9NEWS Northern Colorado reporter Amanda Gilbert captured a photo of one not-so-cute rabbit with the growth on its head, which resident Susan Mansfield said looked like 'black quills or black toothpicks sticking out all around his or her mouth.' 'I thought he would die off during the winter, but he didn't. He came back a second year, and it grew,' Mansfield added. Photos of another rabbit, whose growths have almost completely covered its face, have also gone viral on Reddit. Colorado Parks and Wildlife officials have identified the cause as shope papillomavirus, a rabbit-only virus with no cure that produces wart-like tumours known as papillomas, particularly around the face and head of cottontail rabbits, 9NEWS reports. The virus only spreads among rabbits, primarily by biting insects like fleas and ticks during warmer months. A relative of human papillomavirus, SPV is not harmful to humans, pets or other wildlife, and usually doesn't hurt the rabbit unless it affects the eyes or mouth, officials said. Officials advise residents to avoid approaching or touching affected rabbits. Most wild rabbits manage well, as the growths often disappear on their own. The rabbits' eerie look has gone viral, with comparisons to 'zombies,' 'aliens, and 'Frankenstein bunnies.' Their antler-like growths may have inspired the North American jackalope legend, some researchers and folklorists say. 'Wow, I kinda feel bad for them,' one person commented on an Instagram post of the affected animals. 'One time I need this to be AI,' another joked. 'Zombies are on the rise,' someone else added on Facebook. 'The rabbit escaped from 'Monty Python and The Holy Grail,'' another person referenced the cult-classic movie's killer rabbit.

Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT
Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT

Yahoo

time18 minutes ago

  • Yahoo

Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT

Bioventus Inc. (NASDAQ:BVS) is one of the . On August 7, Craig-Hallum analyst Chase Knickerbocker reiterated a Buy rating on Bioventus Inc. (NASDAQ:BVS) and set a price target of $15.00. A doctor repairing a foot and ankle injury using the latest sports medicine techniques. The analyst gave the rating after Bioventus Inc. (NASDAQ:BVS) reported its fiscal Q2 results on August 6, with reported revenue of $147.7 million declining 2.4% and organic revenue advancing 6.2%. Diluted earnings per share for Q2 was $0.11 compared to a diluted loss per share of $0.40 in the prior-year period. Bioventus Inc. (NASDAQ:BVS) also reported cash from operations of $25.9 million and non-GAAP earnings of $0.21 per share. Bioventus Inc. (NASDAQ:BVS) is a medical technology company that develops and commercializes proprietary orthobiologic products to treat musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. While we acknowledge the potential of BVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store